Associations between Rs4244285 and Rs762551 gene polymorphisms and age-related macular degeneration

References

• Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844–851.
   PubMed Web of Science ®Google Scholar
• Friedman DS, O’Colmain BJ, Muñoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564–572.
   PubMed Web of Science ®Google Scholar
• Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987;31:291–306.
   PubMed Web of Science ®Google Scholar
• Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598–614.
   PubMed Web of Science ®Google Scholar
• Kishan AU, Modjtahedi BS, Martins EN, et al. Lipids and age-related macular degeneration. Surv Ophthalmol 2011;56:195–213.
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M, Rudolf M, et al. The oil spill in ageing Bruch membrane. Br J Ophthalmol 2011;95:1638–1645.
   PubMed Web of Science ®Google Scholar
• Wang L, Clark ME, Crossman DK, et al. Abundant lipid and protein components of drusen. PLoS One 2010;5:e10329.
   PubMed Web of Science ®Google Scholar
• Sarks SH, Van Driel D, Maxwell L, et al. Softening of drusen and subretinal neovascularization. Trans Ophthalmol Soc UK 1980;100:414–422.
   PubMedGoogle Scholar
• Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch Ophthalmol 1999;117:329–339.
   PubMedGoogle Scholar
• Curcio CA, Presley JB, Millican CL, et al. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp Eye Res 2005;80:761–775.
   PubMed Web of Science ®Google Scholar
• Sarks JP, Sarks SH, Killingsworth MC. Evolution of soft drusen in age-related macular degeneration. Eye 1994;8:269–283.
   PubMed Web of Science ®Google Scholar
• Spencer KL, Olson LM, Schnetz-Boutaud N, et al. Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration. PLoS One 2011;6(3):e17784.
   PubMed Web of Science ®Google Scholar
• Zabalza M, Subirana I, Sala J, et al. Meta-analyses of the association between cytochrome CYP2C19 loss- and gain-of-function polymorphisms and cardiovascular outcomes in patients with coronary artery disease treated with clopidogrel. Heart 2012;98:100–108.
   PubMed Web of Science ®Google Scholar
• Cornelis M, El-Sohemy A, Campos H. Genetic polymorphism of CYP1A2increases the risk of myocardial infarction. J Med Genet 2004;41:758–762.
   PubMed Web of Science ®Google Scholar
• The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: AREDS Report Number 6. Am J Ophthalmol 2001;132:688–681.
   Web of Science ®Google Scholar
• Seddon JM, Cote J, Page WF, et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005;123:321–327.
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2:e106–116.
   PubMed Web of Science ®Google Scholar
• Klein R, Myers CE, Buitendijk GH, et al. Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium. Am J Ophthalmol 2014;158:513–524.
   PubMed Web of Science ®Google Scholar
• Zerbib J, Delcourt C, Puche N, et al. Risk factors for exudative age-related macular degeneration in a large French case-control study. Graefes Arch Clin Exp Ophthalmol 2014;252:899–907.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol 2003;121:1728–1737.
   PubMed Web of Science ®Google Scholar
• Seddon J, Ajani U, Sperduto R, et al. Dietary fat intake and age-related macular degeneration. Invest Ophthalmol Vis Sci 1994;352003.
   Google Scholar
• Björkhem I, Cedazo-Minguez A, Leoni V, et al. Oxysterols and neurodegenerative diseases. Mol Aspects Med 2009;30:171–179.
   PubMed Web of Science ®Google Scholar
• Björkhem I, Andersson O, Diczfalusy U, et al. Atherosclerosis and sterol 27- hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA 1994;91:8592–8596.
   PubMed Web of Science ®Google Scholar
• Luoma PV. Cytochrome P450s and gene activation – from pharmacology to cholesterol elimination and regression of atherosclerosis. Eur J Pharmacol 2008;64:841–850.
   Web of Science ®Google Scholar
• Kupstyte N, Zaliunas R, Tatarunas V, et al. Effect of clinical factors and gene polymorphisms of CYP2C19*2, *17 and CYP4F2*3 on early stent thrombosis Pharmacogenomics 2015;16:181–189.
   Google Scholar
• Janha RE, Worwui A, Linton KJ, et al. Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution. BMC Evol Biol 2014;14:71.
   PubMed Web of Science ®Google Scholar
• Soyama A, Saito Y, Hanioka N, et al. Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug Metab Pharmacokinet 2005;20:24–33.
   PubMedGoogle Scholar
• Korytina G, Kochetova O, Akhmadishina L, et al. Polymorphisms of cytochrome P450 genes in three ethnic groups from Russia. Balkan Med J 2012;29:252–260.
   PubMed Web of Science ®Google Scholar
• Tsukino H, Kuroda Y, Nakao H, et al. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol 2004;130:99–106.
   PubMed Web of Science ®Google Scholar
• Figueroa JD, Malats N, Garcia-Closas M, et al. Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 2008;29:1955–1962.
   PubMed Web of Science ®Google Scholar
• Altayli E, Gunes S, Yilmaz AF, et al. CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 2009;41:259–266.
   PubMed Web of Science ®Google Scholar
• Villanueva CM, Silverman DT, Murta-Nascimento C, et al. Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 2009;20:121–127.
   PubMed Web of Science ®Google Scholar
• Pavanello S, Mastrangelo G, Placidi D, et al. CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer. Eur J Epidemiol 2010;25:491–500.
   PubMed Web of Science ®Google Scholar
• Cui X, Lu X, Hiura M, et al. Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population. Environ Health Prev Med 2013;18:136–134.
   PubMed Web of Science ®Google Scholar
• Mirzaev KB, Sychev DA, Yugay AS et al. CYP2C19*2, CYP2C19*3, CYP2C19*17 allele and genotype frequencies in clopidogrel-treated patients with coronary heart disease in Russian. J Pharm Pharmacol 2014;2:322–326.
   Google Scholar
• Shin DJ, Kwon J, Park AR, et al. Association of CYP2C19*2 and *3 genetic variants with essential hypertension in Koreans. Yonsei Med J 2012;53:1113–1119.
   PubMed Web of Science ®Google Scholar
• Sychev DA, Denisenko NP, Sizova ZM, et al. The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors. Dovepress Volume 2015;8:111–114.
   Google Scholar
• Butt AL, Lee ET, Klein R, et al. Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study. Ophthalmol 2011;118:1380–1385.
   PubMed Web of Science ®Google Scholar
• Delcourt C, Michel F, Colvez A, et al. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 2001;8:237–249.
   PubMedGoogle Scholar
• Hyman L, Schachat AP, He Q, et al. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol 2000;118:351–358.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1993;100:406–414.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:1804–1812.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Tomany SC, et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003;110:1273–1280.
   PubMed Web of Science ®Google Scholar
• van Leeuwen R, Klaver CC, Vingerling JR, et al. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 2004;137:750–752.
   PubMed Web of Science ®Google Scholar
• Cackett P, Wong TY, Aung T, et al. Smoking, cardiovascular risk factors, and age-related macular degeneration in Asians: the Singapore Malay Eye Study. Am J Ophthalmol 2008;146:960–967,e961.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, Wong TY, Fletcher A, et al. Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 2010;10:31.
   PubMed Web of Science ®Google Scholar
• Smith W, Mitchell P, Leeder SR, et al. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583–587.
   PubMed Web of Science ®Google Scholar
• Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004;111:1280–1287.
   PubMed Web of Science ®Google Scholar
• The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–1708.
   PubMed Web of Science ®Google Scholar
• Cougnard-Grégoire A, Delyfer M-N, Korobelnik J-F., et al. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: The Alienor Study. PLoS One 2014;9:e90973.
   PubMed Web of Science ®Google Scholar
• Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology 2010;117:1989–1995.
   PubMed Web of Science ®Google Scholar
• Nowak M, Swietochowska E, Marek B, et al. Changes in lipid metabolism in women with age-related macular degeneration. Clin Exp Med 2005;4:183–187.
   PubMed Web of Science ®Google Scholar
• Hogg RE, Woodside JV, Gilchrist SE, et al. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 2008;115:1046–1052, e1042.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Wang JJ, Foran S, et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 2002;109:1092–1097.
   PubMed Web of Science ®Google Scholar
• Ulas F, Balbaba M, Ozmen S, et al. Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration. Int Ophthalmol 2013;33:485–491.
   PubMed Web of Science ®Google Scholar
• Klein R, Cruickshanks KJ, Nash SD, et al. The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol 2010;128:750–758.
   PubMed Web of Science ®Google Scholar
• Tan JS, Mitchell P, Smith W, et al. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143–1150.
   PubMed Web of Science ®Google Scholar
• Buch H. Fourteen-year incidence of age-related maculopathy and cause-specific prevalence of visual impairment and blindness in a Caucasian population: the Copenhagen City Eye Study. Acta Ophthalmol Scand 2005;83:400–401.
   PubMedGoogle Scholar
• Blumenkranz MS, Russell SR, Robey M, et al. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552–558.
   PubMed Web of Science ®Google Scholar
• Sanders TA, Haines AP, Wormald R, et al. Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjects. Am J Clin Nutr 1993;57:428–433.
   PubMed Web of Science ®Google Scholar
• Tsang NC, Penfold PL, Snitch PJ, et al. Serum levels of antioxidants and age-related macular degeneration. Doc Ophthalmol 1992;81:387–400.
   PubMed Web of Science ®Google Scholar
• Ebrahimi KB, Handa JT. Lipids, lipoproteins, and age-related macular degeneration. J Lipids 2011:802059.
   Google Scholar
• Cougnard–Grégoire A, Delyfer MN, Korobelnik JF, et al. Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the alienor study. PLoS One 2014;9(3):e90973.
   PubMed Web of Science ®Google Scholar
• Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000;1:507–537.
   PubMed Web of Science ®Google Scholar
• Klaver CC, Klifen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200–206.
   PubMed Web of Science ®Google Scholar
• Souied EH, Benlian P, Amouyel P, et al. The epsilon 4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998;125:353–359.
   PubMed Web of Science ®Google Scholar
• Davignon J, Cohn JS, Mabile L, et al. Apoliporotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999;28:115–143.
   Web of Science ®Google Scholar
• Lee SH, Schloss GJ, Swain JL. Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor. J Biol Chem 2006;275(43):33679–33687.
   Web of Science ®Google Scholar
• Zerbib J, Seddon JM, Richard F, et al. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 2009;4(10):e7341.
   PubMed Web of Science ®Google Scholar
• Chen W, Stambolian D, Edwards AO, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 2010;107(16):7401–7406.
   PubMed Web of Science ®Google Scholar
• Piehler AP, Haug KBF, Wenzel JJ, et al. ABCA-transporters: regulators of cellular lipid transport. Tidsskrift Norske Laegeforening 2007;12:2930–2933.
   Google Scholar